In Conversation

“  The healthcare industry in the GCC has evolved drastically over the past few years and our medical equipment and IT business has also changed—from quantity to… ”
“ ... inflammatory skin disease is a highly promising area for the company because we have a lot of knowledge about the skin. However, we found that… ”
“  Both the Spanish healthcare system and its healthcare professionals are strongly recognised worldwide, which has opened great opportunities in R&D and clinical trials for new treatments… ”
“ I want to give  a lot of credit to the Italian institutions for an open dialogue in solving many different issues together under tight timelines and… ”
“ STADA has changed a lot in the last three or four years ... One aspect of that change is growth, but more importantly, how we achieve… ”
“ I was lucky to have a front row seat in the transformation of what was a small, primary care-focused Italian company into an internatonal biotech. ”
“ Our expectations for 2022 are mainly related to the launches of our products, including a drug for epilepsy and another for psoriasis; it is a year… ”
“ ... we are in a situation of serious demographic decline, not only in Italy, but in other parts of the world like Japan or Spain. This… ”
“ The situation in Italy has changed; there is a new awareness of the importance of the life sciences/pharmaceutical industry ”
“ About 34 of 38 million people living with HIV globally are between Intercontinental and the Global Patient Solutions (GPS) region ”
“ We are the only CDMO represented in the SMI’s Health Systems Task Force ... This foregrounds our positioning as a strategic partner to pharma and a… ”
“ We believe that to concretely help patients, we need not only a traditional and pharmacological commitment but also a social and educational one ”
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here